The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
Article in Cancers (April 2024)
The most recent citing publications are shown below. View all 456 publications that cite this research output on Dimensions.
Article in Cancers (April 2024)
Article in International Journal of Drug Policy (April 2024)
Article in Familial Cancer (April 2024)